Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae

Chinese Medical Journal

Volumn 122, Issue 11, 2009, Pages 1305-1310

  Wang, Dong ^a   Wang, Ying ^b   Liu, You Ning ^b  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Azithromycin; Biofilms; Ciprofloxacin; Haemophilus influenzae; Pulmonary disease, chronic obstructive

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BIOFILM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCANNING ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BIOFILMS; CIPROFLOXACIN; HAEMOPHILUS INFLUENZAE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING;

EID: 68249144224     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.11.013     Document Type: Article

References (23)

1. Murphy TF, Apicella MA. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev Infect Dis 1987; 9: 1-15.
2. Frank SK, Thomas DG, Fadia DH, Shang W, Shawn H, Melissa C. Genetic and molecular characterization of β-lactamase-negative ampicillin-resistant haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob Agents Chemother 2004; 48: 1630-1639.
3. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol 2000; 54: 49-79.
4. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33: 1387-1392.
5. Xie Y, Jia WX, Zeng W, Yang WQ, Cheng X, Li XR, et al. The action of Pseudomonas aeruginosa biofilms in intrinsic drug resistance. Chin Med J 2005; 118: 1615-1622.
6. Greiner LL, Watanabe H, Phillips NJ, Shao J, Morgan A, Zaleski A, et al. Nontypeable Haemophilus influenzae strain 2019 produces a biofilm containing N-acetylneuraminic acid that may mimic sialylated O-linked glycans. Infect Immun 2004; 72: 4249-4260.
7. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006; 296: 202-211.
8. Eldika N, Sethi S. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2006; 12: 118-124.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. M100-S17. 2007. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Soong G, Muir A, Gomez MI, Waks J, Reddy B, Planet P, et al. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest 2006; 116: 2297-2305.
11. Murphy TF, Kirkham C. Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol 2002; 2: 7.
12. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000; 44: 1818-1824.
13. Webster P, Wu S, Webster S, Rich KA, McDonald K. Ultrastructural preservation of biofilms formed by non-typeable Haemophilus influenzae. Biofilms 2004; 1: 165-182.
14. Froeliger EH, Fives-Taylor P. Streptococcus parasanguis fimbria-associated adhesin fap1 is required for biofilm formation. Infect Immun 2001; 69: 2512-2519.
15. O'Toole GA, Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 1998; 28: 449-461.
16. Girard AE, Girard D, English AR, Gootz TD, Cimochowski CR, Faiella JA, et al. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother 1987; 31: 1948-1954.
17. Birminghama MC, Guarinoa R, Hellerb A. Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose. J Antimicrob Chemother 1999; 43 Suppl A: 43-48.
18. Kaji C, Watanabe K, Apicella MA, Watanabe H. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med 2008; 214: 121-128.
19. Roveta S, Schito AM, Marchese A, Schito GC. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Int J Antimicrob Agents 2007; 30: 415-421.
20. Favre-Bonté S, Köhler T, Van Delden C. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J Antimicrob Chemother 2003; 52: 598-604.
21. Nalca Y, Jansch L, Bredenbruch F, Geffers R, Buer J, Haussler S. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 2006; 50: 1680-1688.
22. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
23. Swords WE, Moore ML, Godzicki L, Bukofzer G, Mitten MJ, VonCannon J. Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae. Infect Immun 2004; 72: 106-113